Most Recent
Thomson Geer poaches IP, tech team from HopgoodGanim
Thomson Geer has nabbed top intellectual property and technology lawyer Hayden Delaney and his Queensland- based team from HopgoodGanim.
Start-up denies ex-Fortescue employees developed green iron on company dime
Element Zero has denied claims that three former Fortescue employees, including one executive, misused confidential information and developed a green iron process on the company dime.
Hamilton Locke loses challenge to Sydney law firm’s trade mark
Hamilton Locke has lost its opposition to the trade mark of a Sydney law firm, with a delegate finding the firms' marks were not likely to cause confusion in the legal market.
Real estate listings giant REA accuses rival Domain of scraping its data
News Corp-owned REA Group has sued rival real estate portal Domain, accusing its main competitor of infringing the copyright it owns in property photos and floor plans.
Bayer launches High Court appeal to revive Xarelto patents
Bayer has filed a High Court challenge to a decision that invalidated its patents for blockbuster blood thinner Xarelto, saying it would adversely affect drug research and development.
Burger ad beef between McDonald’s, Hungry Jack’s done
Fast food giant McDonald’s has resolved its dispute over misleading burger ads by Hungry Jack's, ending a heated four-year courtroom battle.
Travelex wins opposition to blockchain tech company’s trade marks
International currency exchange company Travelex has won its opposition to three trade marks by blockchain travel company Travelx.
Katy Perry wins appeal in trade mark fight with Aussie designer
The Full Court has overturned a finding that singer Katy Perry infringed an Australian fashion designer's 'Katie Perry' mark, finding the designer knew of the pop star when she registered the mark.
Pharmacor says AstraZeneca’s Brilinta patent should not have been extended
As it fends off a suit by AstraZeneca seeking to block the sale of a cheaper version of Brilinta, generics maker Pharmacor claims a patent for the heart attack drug should not have been extended.
AI pathology invention just administrative tool, not patentable: IP Australia
AI tech company Paige can't patent a tool to provide quality control for analysis of pathology images, with IP Australia finding the invention is merely an “administrative scheme” to automate the role of human pathologists.